Inhibition of Human Immunodeficiency Virus Type-1 env Expression by C-5 Propyne Oligonucleotides Specific for Rev-Response Element Stem-Loop V
Data up to Jan 2025
Total Citations Per Year
Abstract
References (42)
[21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction
1987 • 5,745 citations
Firefly luciferase gene: structure and expression in mammalian cells.
1987 • 3,088 citations
PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules
1993 • 2,034 citations
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
1993 • 1,306 citations
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA
1989 • 1,280 citations
Cationic liposome-mediated transfection
1989 • 974 citations
A second post-transcriptional trans-activator gene required for HTLV-III replication
1986 • 639 citations
rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.
1989 • 634 citations
Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
1992 • 609 citations
Current concepts in antisense drug design
1993 • 566 citations
Regulation by HIV Rev depends upon recognition of splice sites
1989 • 517 citations
HIV-1 structural gene expression requires binding of the rev trans-activator to its RNA target sequence
1990 • 457 citations
Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes
1988 • 397 citations
HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA
1991 • 376 citations
Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes.
1992 • 334 citations
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus.
1986 • 303 citations
Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.
1989 • 264 citations
Intracellular disposition and metabolism of fluorescently-labled unmodified and modified oligouncleotides microijjected into mammalian cells
1993 • 239 citations
Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides
1989 • 238 citations
Relation of Phenotype Evolution of HIV-1 to Envelope V2 Configuration
1993 • 236 citations
Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
1992 • 231 citations
Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element.
1991 • 226 citations
Implication of RNA structure on antisense oligonucleotide hybridization kinetics
1992 • 223 citations
Oligonucleotide analogues as potential chemotherapeutic agents.
1988 • 221 citations
Translation of mRNA injected into Xenopus oocytes is specifically inhibited by antisense RNA.
1985 • 204 citations
Secondary Structure is the Major Determinant for Interaction of HIV rev Protein with RNA
1990 • 188 citations
Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.
1992 • 159 citations
Functional Analysis of CAR, the Target Sequence for the Rev Protein of HIV-1
1989 • 152 citations
Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.
1992 • 125 citations
Quantitative hybridization-arrant of mRNA InXenopusoocytes using single-tiranded coanplementary DNA or ollgonudeotlde probes
1985 • 111 citations
100-kDa polypeptides in peripheral clathrin-coated vesicles are required for receptor-mediated endocytosis.
1989 • 110 citations
Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure
1990 • 102 citations
Intracellular oligonucleotide hybridization detected by fluorescence resonance energy transfer (FRET)
1994 • 100 citations
Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirus
1992 • 84 citations
Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine
1990 • 67 citations
Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein
1992 • 65 citations
A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1
1992 • 56 citations
In vitroeffect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription
1992 • 46 citations
Non–Sequence-Specific Inhibition of Transferrin Receptor Expression in HL-60 Leukemia Cells by Phosphorothioate Oligodeoxynucleotides
1991 • 43 citations
Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element
1993 • 41 citations
Human immunodeficiency virus type 1 Tat does not transactivate mature trans-acting responsive region RNA species in the nucleus or cytoplasm of primate cells
1991 • 19 citations
Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides
1992 • 17 citations